ENGN
enGene Holdings Inc.
There isn't enough reported data to score ENGN yet.
ENGN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ENGN's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ENGN PE Valuation
ENGN has no meaningful PE right now: it lost money over the past year.
ENGN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Moderate |
Analysts expect ENGN's losses to shrink, with revenue holding steady.
ENGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.07 | -$0.21 |
| Q2 2026 | -$2.17 | -$0.56 |
| Q1 2026 | -$2.25 | -$0.77 |
| Q4 2025 | -$2.29 | -$0.83 |
| Q3 2025 | -$1.86 | +$1.94 |
| Q2 2025 | -$1.61 | +$2.13 |
| Q1 2025 | -$1.48 | +$2.16 |
| Q4 2024 | -$1.46 | +$2.09 |
ENGN is still losing money, but less than at its worst: $2.07 per share over the past year, against $3.80 at its worst in mid-2024.
ENGN Quarterly Revenue
ENGN's revenue is shrinking: $0 last quarter.
ENGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$18.9M | +$7.4M |
| Q2 2026 | -$30.6M | -$7.6M |
| Q1 2026 | -$29.1M | -$3.1M |
| Q4 2025 | -$25.4M | -$5.6M |
| Q3 2025 | -$26.3M | -$19.2M |
| Q2 2025 | -$23M | -$8.7M |
| Q1 2025 | -$26M | -$18.1M |
| Q4 2024 | -$19.8M | -$12.9M |
ENGN has burned cash in almost every quarter: −$104M over the past year, against −$95M the year before.
ENGN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +9.8K shares |
| 1 year | +37% | +18.7M shares |
| 3 years | +341% | +53.9M shares |
ENGN has 70M diluted shares, up 37% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
ENGN Net Leverage
ENGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ENGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.7 | Neutral |
| Stochastic | 50.4 | Neutral |
ENGN's weekly RSI is 46 (neutral) and its Stochastic is 50 (neutral).
ENGN PE vs Healthcare Sector
ENGN has no meaningful PE right now: it lost money over the past year.
ENGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.80 | 27% above |
| 20 week MA | $1.81 | 26% above |
| 50 week MA | $4.79 | 52% below |
| 100 week MA | $5.11 | 55% below |
ENGN has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 55% below its 100-week average.
ENGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $13.1 | $9.23 | -30% |
| 2024 | $9.23 | $6.42 | -30% |
| 2025 | $6.42 | $9.50 | +48% |
| 2026 YTD | $9.50 | $2.28 | -76% |
ENGN has finished lower in two of the last three years. It's down 76% so far in 2026.